Killian S. Hanlon

1.2k citations

16 papers · 782 indexed · 1 hit paper · h-index 12

Co-authors: Casey A. Maguire David P. Corey Adrienn Volak Bence György Benjamin P. Kleinstiver Maryna V. Ivanchenko Cole W. Peters Camilla Lööv
Topics: Virus-based gene therapy research (9 papers)CRISPR and Genetic Engineering (7 papers)RNA Interference and Gene Delivery (6 papers)
Cited by: Sensory Systems Genetics Business and International Management
Journals: Nature Communications Scientific Reports Trends in Pharmacological Sciences
Partner nations: United States Ireland Netherlands

In The Last Decade

Killian S. Hanlon

16 papers receiving 768 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High levels of AAV vector integration into CRISPR-induced DNA breaks

2019 289 citations Killian S. Hanlon, Benjamin P. Kleinstiver et al. Nature Communications profile →

Peers

Countries citing papers authored by Killian S. Hanlon

Since Specialization

Citations

This map shows the geographic impact of Killian S. Hanlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Killian S. Hanlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Killian S. Hanlon more than expected).

Fields of papers citing papers by Killian S. Hanlon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Killian S. Hanlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Killian S. Hanlon. The network helps show where Killian S. Hanlon may publish in the future.

Co-authorship network of co-authors of Killian S. Hanlon

This figure shows the co-authorship network connecting the top 25 collaborators of Killian S. Hanlon. A scholar is included among the top collaborators of Killian S. Hanlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Killian S. Hanlon. Killian S. Hanlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	In vivo selection in non-human primates identifies AAV capsids for on-target CSF delivery to spinal cord 2024 ·Molecular Therapy ·Killian S. Hanlon,Ming Cheng,(unknown),Jae Ryun Ryu,Boram Lee,(unknown),Nikita Patel,Paula Espinoza,(unknown),Yi Gong,Carrie Ng,(unknown),(unknown),Sean W. Clark,(unknown),Woong Sun,Karen Kozarsky,Casey A. Maguire	6
2	An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain Vasculature 2023 ·Human Gene Therapy ·Servio H. Ramirez,Jonathan F. Hale,Siobhán McCarthy,Christian L. Lino Cardenas,(unknown),Killian S. Hanlon,Eloïse Hudry,(unknown),Carrie Ng,Sabyasachi Das,(unknown),(unknown),Rachel E. Bennett,Allison M. Andrews,Patricia L. Musolino,Casey A. Maguire	11
3	Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial Dysfunction 2023 ·Pharmaceutics ·Naomi Chadderton,Arpad Palfi,Daniel Maloney,Matthew Carrigan,(unknown),Killian S. Hanlon,(unknown),Mary O’Reilly,Peter Humphries,Lorraine Cassidy,Paul F. Kenna,Sophia Millington‐Ward,G. Jane Farrar	5
4	Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1F 2023 ·Molecular Therapy ·Cole W. Peters,Killian S. Hanlon,Maryna V. Ivanchenko,Eric Zinn,(unknown),Yaqiao Li,Jonathan M. Levy,David R. Liu,Benjamin P. Kleinstiver,Artur A. Indzhykulian,David P. Corey	21
5	The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal Administration 2021 ·Human Gene Therapy ·Adam W. Beharry,Yi Gong,James C. Kim,Killian S. Hanlon,(unknown),(unknown),Florian Eichler,Ming Cheng,Anat Stemmer‐Rachamimov,Konstantina M. Stanković,(unknown),Carrie Ng,Casey A. Maguire	17
6	Delivering AAV to the Central Nervous and Sensory Systems 2021 ·Trends in Pharmacological Sciences ·Cole W. Peters,Casey A. Maguire,Killian S. Hanlon	31
7	AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear 2021 ·Molecular Therapy — Methods & Clinical Development ·Maryna V. Ivanchenko,Killian S. Hanlon,(unknown),(unknown),Cole W. Peters,Yaqiao Li,(unknown),(unknown),Casey A. Maguire,David P. Corey	47
8	In vivo engineering of lymphocytes after systemic exosome-associated AAV delivery 2020 ·Scientific Reports ·(unknown),Killian S. Hanlon,(unknown),Adrienn Volak,Amine Meliani,Federico Mingozzi,Benjamin P. Kleinstiver,James J. Moon,Casey A. Maguire	25
9	Versatile Role of Rab27a in Glioma: Effects on Release of Extracellular Vesicles, Cell Viability, and Tumor Progression 2020 ·Frontiers in Molecular Biosciences ·Thomas S. van Solinge,Erik R. Abels,(unknown),Killian S. Hanlon,Sybren L. N. Maas,Rosalie Schnoor,Jeroen de Vrij,Xandra O. Breakefield,Marike L. D. Broekman	10
10	Preclinical testing of AAV9-PHP.B for transgene expression in the non-human primate cochlea 2020 ·Hearing Research ·Maryna V. Ivanchenko,Killian S. Hanlon,(unknown),(unknown),(unknown),J. Lafond,Margaret A. Kenna,David P. Corey,Casey A. Maguire	45
11	Novel 199 base pair NEFH promoter drives expression in retinal ganglion cells 2020 ·Scientific Reports ·Sophia Millington‐Ward,Naomi Chadderton,(unknown),(unknown),Killian S. Hanlon,Matthew Carrigan,Peter Humphries,Paul F. Kenna,Arpad Palfi,G. Jane Farrar	9
12	Selection of an Efficient AAV Vector for Robust CNS Transgene Expression 2019 ·Molecular Therapy — Methods & Clinical Development ·Killian S. Hanlon,(unknown),Tetyana P. Buzhdygan,Ming J. Cheng,Miguel Sena‐Esteves,Rachel E. Bennett,(unknown),Roshanak Razmpour,Yi Gong,Carrie Ng,(unknown),(unknown),Simon Dujardin,Servio H. Ramirez,Eloïse Hudry,Casey A. Maguire	103
13	High levels of AAV vector integration into CRISPR-induced DNA breaksbreakdown → 2019 ·Nature Communications ·Killian S. Hanlon,Benjamin P. Kleinstiver,Sara P. Garcia,Mikołaj Piotr Zaborowski,Adrienn Volak,(unknown),(unknown),Alexander A. Sousa,Shengdar Q. Tsai,Niclas E. Bengtsson,Camilla Lööv,Martin Ingelsson,Jeffrey S. Chamberlain,David P. Corey,Martin J. Aryee,J. Keith Joung,Xandra O. Breakefield,Casey A. Maguire,Bence György	289
14	Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate 2018 ·Molecular Therapy — Methods & Clinical Development ·Bence György,(unknown),Maryna V. Ivanchenko,(unknown),(unknown),Killian S. Hanlon,Artur A. Indzhykulian,Adrienn Volak,K. Domenica Karavitaki,(unknown),Mark Vézina,V. K. Berezovskii,Richard T. Born,Maureen T. O’Brien,J. Lafond,Yvan Arsenijévic,Margaret A. Kenna,Casey A. Maguire,David P. Corey	125
15	A Novel Retinal Ganglion Cell Promoter for Utility in AAV Vectors 2017 ·Frontiers in Neuroscience ·Killian S. Hanlon,Naomi Chadderton,Arpad Palfi,Alfonso Blanco,Peter Humphries,Paul F. Kenna,Sophia Millington‐Ward,G. Jane Farrar	24
16	Cell adhesion and neurite extension in response to two proteolytic fragments of laminin 1988 ·Journal of Neuroscience Research ·Sherry L. Rogers,Sally L. Palm,Paul C. Letourneau,Killian S. Hanlon,J B McCarthy,L T Furcht	14

About Killian S. Hanlon

Killian S. Hanlon is a scholar working on Sensory Systems, Genetics and Molecular Biology, having authored 16 papers that have together received 782 indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), CRISPR and Genetic Engineering (7 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Sensory Systems (163 citations), Genetics (325 citations) and Business and International Management (19 citations). Killian S. Hanlon has collaborated with scholars based in United States, Ireland and Netherlands. Frequent co-authors include Casey A. Maguire, David P. Corey, Adrienn Volak, Bence György, Benjamin P. Kleinstiver, Maryna V. Ivanchenko, Cole W. Peters, Camilla Lööv, Niclas E. Bengtsson and Mikołaj Piotr Zaborowski. Their work appears in journals such as Nature Communications, Scientific Reports and Trends in Pharmacological Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact